Omicron, which was first located in South Africa, has now been detected in many countries, from the US to South Korea - Yesterday was announced the first case on Greek soil.
Swiss pharmaceutical company Roche Holding has developed a PCR test that can detect its Omicron mutation Covid-19, which are expected to help countries monitor the spread of the new variant of the virus.
Roche announced today that its recently acquired TIB Molbiol unit has produced three such tests for research use only. At the same time, she announced that she has checked the diagnostic tests for Covid that she already has and all of them can detect when a patient has been infected with the new variant.
The Swiss company completed the acquisition of TIB Molbiol on Wednesday at an unknown price. The second Berlin-based company set up a PCR test for Covid in January 2020, just weeks after the announcement of Covid's first cases.
Source: economytoday